The Department of Experimental Medicine plays a leading role in an intense, multidisciplinary scientific activity that spans from basic research to clinical and translational medicine.
Thanks to funding from prestigious national and international competitive grants, research groups are working to address current health challenges, combining molecular investigation with technological innovation.
The main research lines are organized into strategic areas that include:
Oncology and Immunology: Study of the molecular mechanisms of tumorigenesis, identification of novel prognostic biomarkers, and development of advanced immunotherapeutic strategies.
Endocrine Metabolic Sciences: Cutting edge research on diabetes, obesity, hormonal disorders, and reproductive health, with a focus on precision medicine.
Space Medicine and Biomedical Technologies: Innovative projects, also in collaboration with the Italian Space Agency (ASI), to understand human physiology in extreme environments and to develop new technologies.
Neurosciences and Aging: Investigation of neuroendocrine mechanisms, neurodegenerative diseases, and active aging, supported in part by funding from the PNRR (National Recovery and Resilience Plan).
Epigenetics: Basic research on the regulation of key epigenetic mechanisms and applied research on the role of epigenetics in human health, with particular reference to neurodegenerative diseases, cystic fibrosis, and cancer.
Nutrition and Environment: Studies on the impact of environmental and nutritional factors on human health.
The detailed descriptions of the ongoing projects, together with the scientific leaders and funding agencies, can be viewed through the dedicated sections in the side menu, organized by programme type.